Ken Peters

Dr. Ken Peters is a PhD Int'l Economist, specializing in the Healthcare & Biotechnology area and its impact on worldwide markets & companies. He has been a senior executive for several fortune 500 Healthcare companies for almost 30 years, traveling & living in Europe, South America, Africa, and Asia. His PhD as an International Economist in the Biotechnology field provided critical quantitative analysis on International trade policies in healthcare and Biotech markets. In 1997 he founded World...See more

Dr. Ken Peters is a PhD Int'l Economist, specializing in the Healthcare & Biotechnology area and its impact on worldwide markets & companies. He has been a senior executive for several fortune 500 Healthcare companies for almost 30 years, traveling & living in Europe, South America, Africa, and Asia. His PhD as an International Economist in the Biotechnology field provided critical quantitative analysis on International trade policies in healthcare and Biotech markets. In 1997 he founded World Diagnostics Inc. (NASDAQ), a point of care diagnostic test company. Through strategic partnering, acquisitions, and cross-licensing, World Diagnostics applied technological innovation to establish footholds across markets in 55 countries before being acquired. He has assisted start-ups & existing companies in becoming successful through technological change. He has been highlighted in the Wall Street Journal, published in various healthcare trade journals, a recipient of Dx Health Care Awards, and noted in "Who's Who in American Entrepreneurs". Dr. Peters has been 3X (three times) a guest scholar, at the University of Shanghai, lecturing on International Business and is currently lecturing at the Steven J. Green School of International and Public Affairs at Florida International University in Miami, Florida. He is a senior consultant to Kinetik Corporation an open API platform health care company transforming the "non-emergency medical transportation" industry. Dr. Peters is an author of Biotech thriller novels such as "Off Shore", and his most recent this spring "The Cure". His third biotech thriller "The Hajj Intercept" to be published by the fall of 2022. See less